. We reviewed recent appraisals of a pharmaceutical manufacturer in three major European markets (France; Italy; Germany … medicines was 63 (Germany), 459 (Italy), and 557 days (France). Conclusions: The clinical domains of the EUnetHTA framework are … current management of the condition (unmet need, Italy), the regulatory status (Orphan Designation, Germany), as well as …

This paper compares the determinants and the effects of innovation cooperation on innovation performance at firm level … in five European countries: Belgium, Germany, Norway, Portugal and Switzerland. In a first step we analyse cooperation …. In a third step we investigate the impact of all four categories of cooperation on innovation performance …